The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

This study is testing a cutting-edge cell therapy (CAR-T cells) in people living with HIV to see if it can help restore the immune system's ability to fight the virus. **You may be eligible if...** - You have confirmed HIV infection - You have been on antiretroviral therapy (HIV medication) for more than 12 months - Your HIV viral load is undetectable (below 50 copies/ml) and your immune cell count (CD4) is above 350 - You have no serious liver, heart, or kidney disease **You may NOT be eligible if...** - You have an active Hepatitis B or Hepatitis C infection, or a serious opportunistic infection - You have a serious chronic illness like diabetes or mental illness - You have a history of pancreatitis from HIV medication - You are pregnant or breastfeeding - You have difficulty sticking to medical appointments or following a treatment plan Talk to your doctor to see if this trial is right for you.